First Light Asset Management, LLC
- SEC CIK
- 0001600004
- Latest filing
- Aug 14, 2026
Holdings in Q3 2024
Holdings as of Sep 30, 2024, filed Nov 14, 2024. Long positions only; changes compare share counts with Q2 2024.
- Positions
- 38
- −6 vs. Q2 2024
- Portfolio value
- $1.20B
- +$61.2M (+5.4%) vs. Q2 2024
| Security | Class | Shares | Value | % of portfolio | Share change | Action | History |
|---|---|---|---|---|---|---|---|
| CNTACentessa Pharmaceuticals plc | SPONSORED ADS | 5,940,132 | $95.0M | 7.9% | +1,159,572+24.3% | Added | History |
| FNAParagon 28, Inc. | COM | 10,154,643 | $67.8M | 5.6% | +1,979,811+24.2% | Added | History |
| EVHEvolent Health, Inc. | CL A | 2,298,261 | $65.0M | 5.4% | +852,956+59.0% | Added | History |
| AXGNAxogen, Inc. | COM | 4,090,296 | $57.3M | 4.8% | +746,263+22.3% | Added | History |
| ATRCAtriCure, Inc. | COM | 1,865,536 | $52.3M | 4.4% | −99,167−5.0% | Reduced | History |
| INSMINSMED Inc | COM PAR $.01 | 688,910 | $50.3M | 4.2% | +137,607+25.0% | Added | History |
| CRNXCrinetics Pharmaceuticals, Inc. | COM | 943,611 | $48.2M | 4.0% | −256,897−21.4% | Reduced | History |
| XENEXenon Pharmaceuticals Inc. | COM | 1,181,662 | $46.5M | 3.9% | −124,598−9.5% | Reduced | History |
| NEONeogenomics Inc | COM NEW | 3,076,555 | $45.4M | 3.8% | −706,006−18.7% | Reduced | History |
| DYNDyne Therapeutics, Inc. | COM | 1,257,285 | $45.2M | 3.8% | +874,852+228.8% | Added | History |
| TNDMTandem Diabetes Care Inc | COM NEW | 1,025,307 | $43.5M | 3.6% | +316,825+44.7% | Added | History |
| RAREUltragenyx Pharmaceutical Inc. | COM | 755,102 | $41.9M | 3.5% | −208,044−21.6% | Reduced | History |
| PHLTPerformant Healthcare Inc | COM | 11,210,400 | $41.9M | 3.5% | +696,200+6.6% | Added | History |
| TMDXTransMedics Group, Inc. | COM | 265,734 | $41.7M | 3.5% | −34,866−11.6% | Reduced | History |
| OSCROscar Health, Inc. | CL A | 1,765,892 | $37.5M | 3.1% | −100,030−5.4% | Reduced | History |
| PODDInsulet Corp | Stock | 159,082 | $37.0M | 3.1% | −56,555−26.2% | Reduced | History |
| HCATHealth Catalyst, Inc. | COM | 4,296,490 | $35.0M | 2.9% | +340,401+8.6% | Added | History |
| ANABAnaptysbio, Inc | COM | 948,131 | $31.8M | 2.6% | +168,973+21.7% | Added | History |
| CDMOAvid Bioservices, Inc. | COM | 2,771,853 | $31.5M | 2.6% | +2,771,853 | New | History |
| VERAVera Therapeutics, Inc. | CL A | 705,234 | $31.2M | 2.6% | −300,489−29.9% | Reduced | History |
| PLRXPliant Therapeutics, Inc. | COM | 2,575,546 | $28.9M | 2.4% | −825,667−24.3% | Reduced | History |
| RGENRepligen Corp | COM | 165,873 | $24.7M | 2.1% | +165,873 | New | History |
| NTRANatera, Inc. | COM | 184,939 | $23.5M | 2.0% | −184,129−49.9% | Reduced | History |
| GPCRStructure Therapeutics Inc. | SPONSORED ADS | 506,222 | $22.2M | 1.8% | −84,425−14.3% | Reduced | History |
| BCYCBicycle Therapeutics PLC | SPONSORED ADS | 967,006 | $21.9M | 1.8% | −417,762−30.2% | Reduced | History |
| SIBNSI-BONE, Inc. | COM | 1,526,215 | $21.3M | 1.8% | −947,074−38.3% | Reduced | History |
| KYMRKymera Therapeutics, Inc. | COM | 406,348 | $19.2M | 1.6% | +406,348 | New | History |
| KRMDKORU Medical Systems, Inc. | COM | 5,598,925 | $15.3M | 1.3% | +560,538+11.1% | Added | History |
| GHGuardant Health, Inc. | COM | 648,993 | $14.9M | 1.2% | +232,026+55.6% | Added | History |
| OPRXOptimizeRx Corp | COM NEW | 1,811,611 | $14.0M | 1.2% | −15,350−0.8% | Reduced | History |
| RLAYRelay Therapeutics, Inc. | COM | 1,542,406 | $10.9M | 0.9% | +1,542,406 | New | History |
| AVTRAvantor, Inc. | COM | 359,150 | $9.29M | 0.8% | −236,974−39.8% | Reduced | History |
| MOHMolina Healthcare, Inc. | COM | 26,528 | $9.14M | 0.8% | +26,528 | New | History |
| ASNDAscendis Pharma A/S | SPONSORED ADR | 51,723 | $7.72M | 0.6% | +15,566+43.1% | Added | History |
| NARIInari Medical, Inc. | Stock | 174,590 | $7.20M | 0.6% | −297,794−63.0% | Reduced | History |
| EXASExact Sciences Corp | COM | 69,447 | $4.73M | 0.4% | −55,939−44.6% | Reduced | History |
| ATECAlphatec Holdings, Inc. | COM NEW | 138,006 | $767.3K | 0.1% | −5,189,972−97.4% | Reduced | History |
| SONXSonendo, Inc. | COM | 5,886,207 | $253.7K | <0.1% | +742,592+14.4% | Added | History |
Sold out since Q2 2024 (11)
Positions held at the end of Q2 2024 that are gone from this filing.
| Security | Class | Shares in Q2 2024 | Value in Q2 2024 | % of portfolio in Q2 2024 | History |
|---|---|---|---|---|---|
| LIVNLivaNova PLC | SHS | 710,390 | $38.9M | 3.4% | History |
| RCMR1 RCM Inc. | COM | 2,464,809 | $31.0M | 2.7% | History |
| TCMDTactile Systems Technology Inc | COM | 1,338,902 | $16.0M | 1.4% | History |
| PCVXVaxcyte, Inc. | COM | 139,729 | $10.6M | 0.9% | History |
| SVRASavara Inc | COM | 2,002,219 | $8.07M | 0.7% | History |
| PENPenumbra Inc | COM | 43,108 | $7.76M | 0.7% | History |
| HUMHumana Inc | Stock | 16,139 | $6.03M | 0.5% | History |
| CNCCentene Corp | Stock | 88,827 | $5.89M | 0.5% | History |
| STVNStevanato Group S.p.A. | ORD SHS | 272,833 | $5.00M | 0.4% | History |
| INSPInspire Medical Systems, Inc. | COM | 28,135 | $3.77M | 0.3% | History |
| SLPSimulations Plus, Inc. | COM | 28,259 | $1.37M | 0.1% | History |